Drugs Acting on the Cardiovascular System Quiz 3

1. Milrinone is best used:

2. Glyceryl trinitrate is used in CHF for:

3. Raised plasma aldosterone level in CHF contributes
to disease progression by exerting the following
effects except:

4. The following apply to use of spironolactone in CHF
except:

5. The following is true of β-adrenergic blocker therapy
in CHF:

6. The following drug can relieve symptoms of CHF but
does not retard disease progression or prolong
survival:

7. A patient of CHF was treated with furosemide and
digoxin. He became symptom-free and is stable for
the last 3 months with resting heart rate 68/min in
sinus rhythm but left ventricular ejection fraction is
low. Which of the following lines of action is warranted:

8. Choose the correct statement about use of βadrenergic blockers in CHF:

9. The preferred diuretic for mobilizing edema fluid in
CHF is

10. Beneficial effects of β-adrenoceptor blockers in CHF
include the following except:

11. The following type of vasodilator is not beneficial in
CHF due to systolic dysfunction:

12. Select the drug which is an ‘inodilator’ beneficial in
refractory congestive heart failure:

13. The following action of digoxin is responsible for
beneficial effect in auricular fibrillation:

14. Select the drug that can help restore cardiac performance as well as prolong survival in CHF patients:

15. Digoxin produces the following effect(s) in atrial flutter:

16. Beneficial effect/effects of diuretics in CHF patients
include the following:

17. Which vasodilator is most suitable for a patient of
CHF who is symptomatic even at rest and has a
central venous pressure of 25 mm Hg and cardiac
index 1.8 L/min/m2:

18. The principal action common to all class I antiarrhythmic
drugs is:

19. The following drug is used for short-term control of
emergency heart failure, but not for long-term treatment of congestive heart failure:

20. Vasodilators are used to treat: